Comparison of Two Methods for Estimating MS-Related Mortality: The Excess Mortality vs. the Cause-Specific Frameworks.

cause-specific excess hazard multiple sclerosis observational study probability of death

Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
12 Oct 2023
Historique:
received: 17 07 2023
accepted: 11 09 2023
medline: 13 10 2023
pubmed: 13 10 2023
entrez: 12 10 2023
Statut: aheadofprint

Résumé

Determining whether multiple sclerosis (MS) causes death is challenging. Our objective was to contrast two frameworks to estimate probabilities of death attributed to MS (P We used data from the In the comparative subset, the estimated 30-year P EMF has the strong advantage of not requiring death certificates, which quality is sub-optimal. Conceptually, it also appears more relevant as it avoids having to state, for each individual, if death was directly or indirectly caused by MS or if it would have occurred anyway, which is especially difficult in such chronic diseases.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
Determining whether multiple sclerosis (MS) causes death is challenging. Our objective was to contrast two frameworks to estimate probabilities of death attributed to MS (P
METHODS METHODS
We used data from the
RESULTS RESULTS
In the comparative subset, the estimated 30-year P
DISCUSSION CONCLUSIONS
EMF has the strong advantage of not requiring death certificates, which quality is sub-optimal. Conceptually, it also appears more relevant as it avoids having to state, for each individual, if death was directly or indirectly caused by MS or if it would have occurred anyway, which is especially difficult in such chronic diseases.

Identifiants

pubmed: 37827849
pii: WNL.0000000000207925
doi: 10.1212/WNL.0000000000207925
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

Auteurs

Fabien Rollot (F)

Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, Lyon, France.
EUGENE DEVIC EDMUS Foundation against multiple sclerosis, state-approved foundation, Bron, France.

Zoe Uhry (Z)

Direction des Maladies non Transmissible et des Traumatismes, Santé Publique France, Saint-Maurice, France.
Service de Biostatistique-Bioinformatique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France.

Emmanuelle Dantony (E)

Service de Biostatistique-Bioinformatique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France.
Laboratoire de Biométrie et Biologie Evolutive UMR 5558, Université Lyon 1 and CNRS, Villeurbanne, France.

Sandra Vukusic (S)

Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, Lyon, France.
EUGENE DEVIC EDMUS Foundation against multiple sclerosis, state-approved foundation, Bron, France.

Marc Debouverie (M)

Service de Neurologie, Centre Hospitalier Régional et Universitaire de Nancy, Université de Lorraine, EA 4360 APEMAC, Vandoeuvre-Lès-Nancy, France.

Emmanuelle Le Page (E)

Neurology Department, CRCSEP Rennes, Clinical Investigation Centre CIC-P 1414, Rennes University Hospital, France.

Jonathan Ciron (J)

Service de Neurologie, CHU de Toulouse, Hôpital Pierre-Paul Riquet, CRC-SEP, Toulouse, France.
Institut Toulousain des Maladies infectieuses et Inflammatoires (Infinity), INSERM UMR 1291, CNRS UMR 5051, Université Toulouse III, Toulouse, France.

Aurélie Ruet (A)

Service de Neurologie, CRC SEP, CHU de Bordeaux, Bordeaux, France.
U1215 INSERM, Neurocentre Magendie, Université de Bordeaux, Bordeaux, France.

Jerome De Seze (J)

Service de Neurologie et Centre d'Investigation Clinique, CHU de Strasbourg, INSERM 1434, Strasbourg, France.

Helene Zephir (H)

Pôle des neurosciences et de l'appareil locomoteur, CRC-SEP, Hôpital Roger Salengro, Université de Lille, Inserm U1172, Lille, France.

Pierre M Labauge (PM)

CRC SEP, Service de Neurologie, CHU de Montpellier, 34295 Montpellier Cedex 5, France.

Gilles Defer (G)

Service de Neurologie, CRC -SEP Normandie, CHU de Caen, Université Normandie, Caen, France.

Christine Lebrun-Frenay (C)

Service de Neurologie, Neurologie Pasteur 2, CHU de Nice, Université Nice Cote d'Azur UR2CA-URRIS, Nice, France.

Thibault Moreau (T)

Service de Neurologie, CHU de Dijon, Dijon, France.

David A Laplaud (DA)

Service de Neurologie, CHU Nantes, Nantes, France.
INSERM, CIC 0004, CRTI-INSERM UMR U1064, Nantes, France.

Eric Berger (E)

Service de Neurologie, CHU de Besançon, Besançon, France.

Pierre Clavelou (P)

Service de Neurologie, CHU de Clermont-Ferrand, INSERM 1107 NeuroDol, Clermont-Ferrand, France.

Jean Pelletier (J)

Aix Marseille University, APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, CEMEREM,13005 Marseille, France.

Eric Thouvenot (E)

Service de Neurologie, CHU de Nîmes, Nîmes, France.
Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.

Olivier Heinzlef (O)

Service de Neurologie, CH de Poissy, Poissy, France.

Jean-Philippe Camdessanche (JP)

Service de Neurologie, Hôpital Nord, CHU Saint-Étienne, Saint-Etienne, France.

Mathieu Fauvernier (M)

Service de Biostatistique-Bioinformatique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France.
Laboratoire de Biométrie et Biologie Evolutive UMR 5558, Université Lyon 1 and CNRS, Villeurbanne, France.

Laurent Remontet (L)

Service de Biostatistique-Bioinformatique, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France.
Laboratoire de Biométrie et Biologie Evolutive UMR 5558, Université Lyon 1 and CNRS, Villeurbanne, France.

Emmanuelle Leray (E)

Univ Rennes, EHESP, CNRS, Inserm, ARENES UMR 6051, RSMS U 1309, Rennes, France; emmanuelle.leray@ehesp.fr.

Classifications MeSH